ImmuNovus
Denton, US · Founded 2022
Founders & leadership
TH
Tomas HelikarExecutive Officer
Reported raises · per SEC filings
Form D private placements$1MraisedJul 2026 · 2 investors · Other Technology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.